Ki Summary

Reaction Details

Report a problem with these data

Target

Integrase

Ligand

BDBM294624

Substrate/Competitor

n/a

Meas. Tech.

Anti-HIV Activity MT4 Assay

IC50

2.00±n/a nM

Citation

Johns, BA; Velthuisen, EJ; Weatherhead, JG; Suwandi, L; Temelkoff, D Isoindoline derivatives for use in the treatment of a viral infection US Patent US10112899 Publication Date 10/30/2018

More Info.:

Get all data from this article, Assay Method

Integrase

Name:

Integrase

Synonyms:

Human immunodeficiency virus type 1 integrase

Type:

PROTEIN

Mol. Mass.:

32231.48

Organism:

Human immunodeficiency virus 1

Description:

ChEMBL_90865

Residue:

288

Sequence:

FLDGIDKAQDEHEKYHSNWRAMASDFNLPPVVAKEIVASCDKCQLKGEAMHGQVDCSPGI
WQLDCTHLEGKVILVAVHVASGYIEAEVIPAETGQETAYFLLKLAGRWPVKTIHTDNGSN
FTSTTVKAACWWAGIKQEFGIPYNPQSQGVVESMNKELKKIIGQVRDQAEHLKTAVQMAV
FIHNFKRKGGIGGYSAGERIVDIIATDIQTKELQKQITKIQNFRVYYRDSRDPLWKGPAK
LLWKGEGAVVIQDNSDIKVVPRRKVKIIRDYGKQMAGDDCVASRQDED

BDBM294624

n/a

Name

BDBM294624

Synonyms:

(S)-2-(tert-butoxy)-2-((M)-2-(3,3-dimethylbutanoyl)-6-(8-fluoro-5-methylchroman-6-yl)-4,7-dimethylisoindolin-5-yl)acetic acid | US10112899, Example 104

Type

Small organic molecule

Emp. Form.

C32H42FNO5

Mol. Mass.

539.678

SMILES

Cc1c2CN(Cc2c(C)c(-c2cc(F)c3OCCCc3c2C)c1[C@H](OC(C)(C)C)C(O)=O)C(=O)CC(C)(C)C |r,wD:23.27,(3.24,-2.17,;1.9,-1.4,;.57,-2.17,;.25,-3.68,;-1.28,-3.84,;-1.91,-2.43,;-.77,-1.4,;-.77,.14,;-2.1,.91,;.57,.91,;.57,2.45,;1.9,3.22,;1.9,4.76,;3.24,5.53,;.57,5.53,;.57,7.07,;-.77,7.84,;-2.1,7.07,;-2.1,5.53,;-.77,4.76,;-.77,3.22,;-2.1,2.45,;1.9,.14,;3.24,.91,;3.24,2.45,;4.57,3.22,;5.9,2.45,;4.57,4.76,;5.9,3.99,;4.57,.14,;5.9,.91,;4.57,-1.4,;-2.05,-5.17,;-1.28,-6.51,;-3.59,-5.17,;-4.36,-6.51,;-5.9,-6.51,;-3.59,-7.84,;-5.13,-7.84,)|

Structure